🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/10/2009 11,16 11,22 10,68 10,68 -4,81% 4,84% 267.800
15/10/2009 11,22 11,22 10,80 11,22 +0,00% 3,74% 342.567
14/10/2009 11,40 11,40 10,92 11,22 +1,08% 4,21% 188.517
13/10/2009 11,40 11,46 10,86 11,10 +4,52% 5,26% 378.050
12/10/2009 11,04 11,16 10,62 10,62 -2,21% 4,89% 234.550
09/10/2009 11,04 11,04 10,62 10,86 -1,09% 3,80% 349.450
08/10/2009 11,52 11,52 10,92 10,98 -3,68% 5,21% 257.383
07/10/2009 10,86 11,64 10,56 11,40 +4,97% 9,94% 593.117
06/10/2009 11,52 11,52 10,62 10,86 -5,73% 7,81% 759.883
05/10/2009 11,94 12,48 10,98 11,52 +23,08% 12,56% 3.929.083
02/10/2009 9,18 9,72 9,06 9,36 -4,29% 7,19% 202.583
01/10/2009 10,20 10,32 9,54 9,78 -5,23% 7,65% 388.483
30/09/2009 9,60 10,32 8,94 10,32 +10,26% 14,38% 905.650
29/09/2009 9,66 9,78 9,24 9,36 -3,11% 5,59% 296.750
28/09/2009 9,66 9,96 9,66 9,66 +0,00% 3,11% 262.717
25/09/2009 10,14 10,14 9,36 9,66 -4,17% 7,69% 397.250
24/09/2009 10,80 10,86 9,96 10,08 -6,67% 8,33% 317.700
23/09/2009 11,04 11,22 10,80 10,80 -0,55% 3,80% 385.850
22/09/2009 10,86 10,98 10,50 10,86 +1,12% 4,42% 448.383
21/09/2009 11,04 11,04 10,56 10,74 -0,56% 4,35% 247.200
18/09/2009 11,04 11,28 10,56 10,80 -3,23% 6,52% 498.417
17/09/2009 11,94 11,94 11,10 11,16 -6,06% 7,04% 428.933
16/09/2009 11,52 11,88 11,16 11,88 +4,21% 6,25% 450.633
15/09/2009 11,34 11,70 11,16 11,40 -2,06% 4,76% 428.467
14/09/2009 11,46 13,32 11,16 11,64 -5,37% 18,85% 1.761.950
11/09/2009 10,62 12,30 10,38 12,30 +13,89% 18,08% 1.143.133
10/09/2009 10,38 10,80 10,02 10,80 +3,45% 7,51% 501.317
09/09/2009 11,10 11,10 10,38 10,44 -4,40% 6,49% 396.533
08/09/2009 11,10 11,28 10,32 10,92 +1,68% 8,65% 554.667
04/09/2009 10,86 10,98 9,96 10,74 +0,00% 9,39% 836.433